TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2025

Brentuximab Vedotin Combination for Relapsed Diffuse Large B-Cell Lymphoma.

Nancy L Bartlett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.